ClinVar Miner

Submissions for variant NM_007175.8(ERLIN2):c.47_48delinsAA (p.Cys16Ter)

dbSNP: rs2487278624
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory of Human Molecular Genetics, Federal University of Alagoas RCV003327253 SCV004032060 pathogenic Hereditary spastic paraplegia 18 2023-09-05 criteria provided, single submitter research This sequence change creates a premature translational stop signal (c.47_48delinsAA; p.Cys16*) in the ERLIN2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with ERLIN2-related conditions. Loss-of-function variants in ERLIN2 are known to be pathogenic (PMID: 21330303, 23109145, 24482476, 27824013). For these reasons, this variant has been classified as Pathogenic. Also, all four patients displayed childhood cataract, expanding the known clinical spectrum of SPG18.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.